[1] |
.SHU A,YIN M T,STEIN E,et a1. Bone structure and turnover in type 2 diabetes mellitus[J]. Osteoporos Int,2012,23(2):635-641.
|
[2] |
.王蓉,沈安达,朱福瑛,等. 血清组织蛋白酶K在骨质疏松症诊断中的应用[J]. 检验医学,2016,31(8):647-651.
|
[3] |
.肖恩,孟萍. 骨质疏松骨代谢生化指标的研究进展[J]. 中国骨质疏松杂志,2008,14(3):212-216.
|
[4] |
.阚全娥,杨慧慧. 绝经后2型糖尿病患者骨密度与骨代谢标志物的相关分析[J]. 中华老年医学杂志,2013,32(11):1206-1208.
|
[5] |
.PENNISI P,SIGNORELLI S S,RICCOBENE S,et al.Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels[J]. Osteoporos Int,2004,15(5):389-395.
|
[6] |
.张晓波,邓士琳. 日常性体力活动与绝经后骨质疏松症发病风险的关联性[J]. 吉林大学学报(医学版),2012,38(4):775-778.
|
[7] |
.张敏,李智,魏琦,等. 糖化血红蛋白与骨代谢生化指标相关性的探讨[J]. 检验医学,2014,29(4):324-327.
|
[8] |
.赵花,张丽侠,郑丽丽. 2型糖尿病患者血糖控制水平对骨密度的影响[J]. 郑州大学学报(医学版),2015,59(1):124-127.
|
[9] |
.郁静嘉,赵点点,王筱婧,等. 血清25-羟维生素D和甲状旁腺激素水平与2型糖尿病患者骨密度的关系[J]. 中华内分泌代谢杂志,2015,31(4):306-310.
|
[10] |
.BHATTOA H P,NAGY E,MORE C,et a1. Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age:the HunMen Study[J]. Osteoporos Int,2013,24(1):179-186.
|
[11] |
.VAN DRIEL M,KOEDAM M,BUURMAN C J,et a1. Evidence for auto/paracrine actions of vitamin D in bone:1 alpha-hydroxylase expression and activity in human bone cells[J]. FASEB J,2006,20(13):2417-2419.
|
[12] |
.AL-TIMIMI D J,ALI A F. Serum 25(OH)D in diabetes mellitus type 2:relation to glycaemic control[J]. J Clin Diagn Res,2013,7(12):2686-2688.
|
[13] |
.童明宏,肖国平,丁慧. 骨质疏松症与骨转换标志物的相关性研究[J]. 检验医学,2013,28(2):111-113.
|
[14] |
.GARNERO P.The contribution of collagen crosslinks to bone strength[J]. Bonekey Rep,2012,1:182.
|
[15] |
.HUOPIO J,KRGER H,HONKANEN R,et al.Risk factors for perimenopausal fractures:a prospective study[J]. Osteoporos Int,2000,11(3):219-227.
|